SAGE THERAPEUTICS INC (SAGE) Stock Analyst Earnings Estimates
NASDAQ:SAGE - Nasdaq - US78667J1088 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.7M 22.22% | 86.455M 1,022.79% | 41.243M -52.30% | 84.741M 105.47% | 141.97M 67.53% | 151.45M 6.68% | 240.89M 59.06% | 344.76M 43.12% | 370.11M 7.35% | 429.01M 15.91% | 538.83M 25.60% | |
| EBITDA YoY % growth | -545.9M -19.53% | -545.07M 0.15% | -409.485M 24.87% | -261.424M 36.16% | -185.644M 28.99% | -124.44M 32.97% | -65.688M 47.21% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -547M -18.68% | -546.463M 0.10% | -410.516M 24.88% | -245.41M 40.22% | -199.66M 18.64% | -151.102M 24.32% | -56.061M 62.90% | 31.213M 155.68% | 30.477M -2.36% | 51.05M 67.50% | 117M 129.19% | |
| Operating Margin | -7,103.90% | -632.08% | -995.36% | -289.60% | -140.64% | -99.77% | -23.27% | 9.05% | 8.23% | 11.90% | 21.71% | |
| EPS YoY % growth | -8.98 -15.13% | -10.31 -14.81% | -6.59 36.08% | -3.55 46.14% | -2.77 22.05% | -1.58 42.72% | -1.47 7.31% | 0.04 102.50% | 0.42 1,044.44% | 0.89 112.38% | 3.06 242.48% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.01 43.88% | -0.92 46.14% | -0.85 44.31% | -0.85 45.27% | -1.06 -5.00% | -1.03 -12.52% | -0.98 -14.91% | -0.60 29.51% |
| Revenue Q2Q % growth | 14.618M 84.99% | 16.898M 95.26% | 21.156M 78.22% | 27.161M 111.95% | 32.13M 119.80% | 37.903M 124.30% | 45.492M 115.03% | 74.154M 173.02% |
| EBITDA Q2Q % growth | -79.82M 31.97% | -74.845M 32.36% | -73.996M 26.23% | -73.064M 7.87% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -72.974M 37.99% | -68.839M 38.15% | -63.738M 37.02% | -60.803M 24.32% | -71.029M 2.67% | -69.102M -0.38% | -65.614M -2.94% | -42.012M 30.91% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -1.56 13.33% | -1.54 | -0.02 | -1.61% |
| Q3 2024 Q2Q % growth | -1.53 54.60% | -1.56 | 0.03 | 2.18% |
| Q2 2024 Q2Q % growth | -1.70 36.57% | -1.69 | -0.01 | -0.48% |
| Q1 2024 Q2Q % growth | -1.80 26.83% | -1.68 | -0.12 | -7.14% |
| Q4 2023 Q2Q % growth | -1.80 27.13% | -1.30 | -0.50 | -38.16% |
| Q3 2023 Q2Q % growth | -3.37 -45.89% | -2.79 | -0.58 | -21.00% |
| Q2 2023 Q2Q % growth | -2.68 -25.82% | -2.60 | -0.08 | -2.89% |
| Q1 2023 Q2Q % growth | -2.46 -18.84% | -2.55 | 0.09 | 3.37% |
| Q4 2022 Q2Q % growth | -2.47 -16.51% | -2.44 | -0.03 | -1.43% |
| Q3 2022 Q2Q % growth | -2.31 -4.52% | -2.25 | -0.06 | -2.60% |
| Q2 2022 Q2Q % growth | -2.13 -16.39% | -2.20 | 0.07 | 2.98% |
| Q1 2022 Q2Q % growth | -2.07 -26.22% | -2.08 | 0.01 | 0.35% |
| Q4 2021 Q2Q % growth | -2.12 -111.65% | -2.21 | 0.09 | 4.29% |
| Q3 2021 Q2Q % growth | -2.21 -8.87% | -1.89 | -0.32 | -16.91% |
| Q2 2021 Q2Q % growth | -1.83 12.02% | -1.73 | -0.10 | -5.95% |
| Q1 2021 Q2Q % growth | -1.64 32.79% | -1.95 | 0.31 | 15.77% |
| Q4 2020 Q2Q % growth | 18.19 659.69% | -0.36 | 18.55 | 5,163.12% |
| Q3 2020 Q2Q % growth | -2.03 41.67% | -2.43 | 0.40 | 16.61% |
| Q2 2020 Q2Q % growth | -2.08 36.59% | -2.71 | 0.63 | 23.32% |
| Q1 2020 Q2Q % growth | -2.44 27.60% | -3.20 | 0.76 | 23.77% |
| Q4 2019 Q2Q % growth | -3.25 | -3.68 | 0.43 | 11.63% |
| Q3 2019 Q2Q % growth | -3.48 | -3.43 | -0.05 | -1.41% |
| Q2 2019 Q2Q % growth | -3.28 | -3.40 | 0.12 | 3.47% |
| Q1 2019 Q2Q % growth | -3.37 | -3.31 | -0.06 | -1.71% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 12.815M -83.56% | 14.729M | -1.914M | -12.99% |
| Q3 2024 Q2Q % growth | 11.871M 337.08% | 11.018M | 853K | 7.74% |
| Q2 2024 Q2Q % growth | 8.654M 250.36% | 9.025M | -371K | -4.11% |
| Q1 2024 Q2Q % growth | 7.902M 139.89% | 5.891M | 2.011M | 34.14% |
| Q4 2023 Q2Q % growth | 77.972M 2,588.69% | 62.197M | 15.775M | 25.36% |
| Q3 2023 Q2Q % growth | 2.716M 59.76% | 4.71M | -1.994M | -42.34% |
| Q2 2023 Q2Q % growth | 2.47M 64.67% | 3.002M | -532K | -17.72% |
| Q1 2023 Q2Q % growth | 3.294M 105.88% | 2.454M | 840K | 34.23% |
| Q4 2022 Q2Q % growth | 2.9M 81.25% | 1.977M | 923K | 46.69% |
| Q3 2022 Q2Q % growth | 1.7M 21.43% | 1.672M | 28K | 1.67% |
| Q2 2022 Q2Q % growth | 1.5M -6.25% | 1.797M | -297K | -16.53% |
| Q1 2022 Q2Q % growth | 1.6M | 3.271M | -1.671M | -51.09% |
| Q4 2021 Q2Q % growth | 1.6M -99.86% | 2.014M | -414K | -20.56% |
| Q3 2021 Q2Q % growth | 1.4M -12.50% | 1.998M | -598K | -29.93% |
| Q2 2021 Q2Q % growth | 1.6M 45.45% | 2.048M | -448K | -21.88% |
| Q1 2021 Q2Q % growth | 1.6M -30.43% | 2.043M | -443K | -21.68% |
| Q4 2020 Q2Q % growth | 1.109B 55,360.00% | 56.447M | 1.053B | 1,865.03% |
| Q3 2020 Q2Q % growth | 1.6M -55.56% | 1.903M | -303K | -15.92% |
| Q2 2020 Q2Q % growth | 1.1M 22.22% | 905.281K | 194.719K | 21.51% |
| Q1 2020 Q2Q % growth | 2.3M 360.00% | 2.852M | -552K | -19.35% |
| Q4 2019 Q2Q % growth | 2M | 3.756M | -1.756M | -46.75% |
| Q3 2019 Q2Q % growth | 3.6M | 3.674M | -74K | -2.01% |
| Q2 2019 Q2Q % growth | 900K | 262.364K | 637.636K | 243.03% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 22.32% | 35.27% | 9.84% | 15.58% |
| Revenue | -10.38% | -24.35% | -3.99% | -2.49% |